No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

NCT00125047Phase 4Completed27231 enrolled

View all 1 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Comparison of the efficacy of cefoperazone-sulbactam and other cephalosporins in the treatment of infections: A systematic review and meta-analysis.

Sun Wenwei, Zhang Jieying, Miao Ke et al. · Medicine (Baltimore) · 2025

PMID: 40295277Meta-AnalysisFull text (PMC)

Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis.

Wu Rui, Wang Xuechang, Cui Pumei et al. · J Chemother · 2024

PMID: 38644652Meta-Analysis

Clinical Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis.

Lan Shao-Huan, Chao Chien-Ming, Chang Shen-Peng et al. · Surg Infect (Larchmt) · 2021

PMID: 33625294Meta-Analysis

Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis.

Lan Shao-Huan, Chang Shen-Peng, Lai Chih-Cheng et al. · Medicine (Baltimore) · 2020

PMID: 32080150Meta-AnalysisFull text (PMC)

Effectiveness of Cefoperazone-sulbactam alone and Combined with Tigecycline in the Treatment of Multi-drug Resistant Acinetobacter Baumannii Pulmonary Infection.

Lv Qin, Deng Yanling, Zhu Xiaobo et al. · J Coll Physicians Surg Pak · 2020

PMID: 32169149RCT

Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteers.

Kaewvichit Sayam, Yotsawimonwat Songwut, Taesotikul Wandee et al. · J Med Assoc Thai · 2008

PMID: 19127801RCT

Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia.

Xu Shuyun, Xiong Shengdao, Xu Yongjian et al. · J Huazhong Univ Sci Technolog Med Sci · 2006

PMID: 17120738RCT

[Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].

Huang Jian-jun, Zeng Qiang, Yu Jia-lu · Di Yi Jun Yi Da Xue Xue Bao · 2005

PMID: 16174597RCT

Efficacy of cefoperazone-sulbactam as a component of combination therapy for carbapenem-resistant Acinetobacter baumannii bloodstream infection in intensive care units: a multicenter retrospective propensity score-matched study.

Wang Sheng-Huei, Lin Yu-Chao, Chan Ming-Cheng et al. · BMC Infect Dis · 2025

PMID: 40597720ObservationalFull text (PMC)

Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment.

Chiang Tsung-Ta, Chiang Ming-Hsien, Tang Hung-Jen et al. · Eur J Clin Microbiol Infect Dis · 2024

PMID: 38995342ObservationalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Cefoperazone (substance)
SNOMED CT: 372743004
UMLS CUI: C0007552
RxNorm CUI: 2184

Clinical Data

This intervention maps to 16 entities in the Healos knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.